Apr 21, 2016· Comment from National Community Pharmacists Association (NCPA)· FDA-2015-N-4809-0040
Attached please find comments submitted by the National Community Pharmacists Association (NCPA).
FDANonrulemakingFDA-2015-N-4809
Patient and Medical Professional Perspectives on the Return of Genetic Test Results
RIN
—
Last modified
Apr 21, 2016
Comment window
closed 3771d ago
National Community Pharmacists Association filings
1
Activity
National Community Pharmacists Association filed 1 comment on this docket between Apr 21, 2016 and Apr 21, 2016. 10 other organizations filed here. The comment window closed 3771d ago.
What National Community Pharmacists Association filed (1)
Abstract
No abstract recorded.
View on regulations.gov →Co-filers (10)
See everyone who commented →- National Community Pharmacists AssociationTHIS ORG1 filing · confidence 97%
- American Academy of Pediatrics (AAP)1 filing · confidence 97%
- American Association for Clinical Chemistrytrade assoc.1 filing · confidence 85%
- American Pharmacists Association (APhA)trade assoc.1 filing · confidence 97%
- American Society for Investigative Pathologytrade assoc.1 filing · confidence 85%
- Association for Molecular Pathologytrade assoc.1 filing · confidence 85%
- Coriell Institute for Medical Researchtrade assoc.1 filing · confidence 85%
- Florida Pharmacy Associationtrade assoc.1 filing · confidence 85%
- Icahn Institute for Genomics and Multiscale Biology (Icahn) at Mount Sinaitrade assoc.1 filing · confidence 85%
- National Alliance of State Pharmacy Associationstrade assoc.1 filing · confidence 85%
- University of Florida Health Personalized Medicine Program Leadership Teamunverified attribution1 filing · confidence 70%